Characterizing Carbapenemase Gene Transmission in CREC: Insights from Guangdong, China (2022–2024)

Study Background and Research Question

The global expansion of carbapenem-resistant Enterobacteriaceae (CRE) poses a severe threat to clinical care, with Enterobacter cloacae (CREC) ranking among the top three CRE species in China. The COVID-19 pandemic has further complicated infection management by increasing antibiotic usage and healthcare interruptions, potentially accelerating antimicrobial resistance (AMR) emergence. However, the molecular epidemiology and transmission dynamics of carbapenemase-encoding genes (CEGs) in CREC during this unique period remain poorly understood. The reference study specifically addressed this gap by systematically analyzing CEG prevalence, localization, and mobility in CREC isolates from eight teaching hospitals in Guangdong Province collected from December 2022 to June 2024.

Key Innovation from the Reference Study

The principal innovation of this work is the comprehensive, post-pandemic mapping of carbapenemase gene diversity and mobility in a high-risk hospital environment. By integrating molecular typing, resistance profiling, and plasmid conjugation assays, the authors delineated not only the frequency of key CEGs—especially blaNDM-1—but also their chromosomal versus plasmid distribution and transmissibility. The study’s approach captures both the vertical and horizontal gene transfer landscape, providing actionable insight into how resistance determinants disseminate under contemporary clinical pressures.

Methods and Experimental Design Insights

The research employed a robust combination of classic and molecular microbiology techniques:

• Sample Collection: 54 non-redundant CREC isolates were collected from eight tertiary hospitals, representing a diverse clinical background.
• CEG Detection: PCR assays targeted blaNDM-1, blaIMP, and blaKPC-2 to assess gene prevalence and genetic context.
• Plasmid Localization and Elimination: The variable temperature SDS plasmid elimination method was used to distinguish gene location on plasmids versus chromosomes.
• Antibiotic Susceptibility: The broth microdilution method compared resistance profiles between CEG-positive and CEG-negative groups across multiple antibiotics, including ciprofloxacin and levofloxacin.
• Plasmid Conjugation and Mobility: Transfer experiments assessed the efficiency of horizontal gene transfer for each CEG subtype.
• Genotyping: ERIC-PCR and NTSYS clustering were applied to categorize isolates and trace epidemiological distribution across clinical departments and patient demographics.
• Mobile Genetic Element Analysis: PCR identified six classes of mobile elements, with ISEcp1 being the most common.

This multifaceted approach enabled fine-scale dissection of both gene prevalence and transmission potential, supporting downstream modeling of AMR spread.

Core Findings and Why They Matter

The study’s results reveal several clinically and experimentally significant patterns:

• High CEG Prevalence: 85.19% (46/54) of isolates harbored at least one CEG, with blaNDM-1 as the dominant variant, found in both chromosomal (33.33%) and plasmid (46.30%) contexts. This dual localization underscores the gene’s stability and transfer potential.
• Plasmid-Mediated Resistance: The majority of blaNDM-1 and all blaIMP genes were plasmid-borne, supporting rapid horizontal transfer. Plasmid conjugation experiments confirmed high transfer efficiencies (95.65% overall), especially for blaNDM-1 and blaIMP, while blaKPC-2 showed no successful conjugative transfer in this series.
• Multidrug Resistance Patterns: CEG-positive strains exhibited significantly elevated resistance rates across carbapenems, cephalosporins, aminoglycosides, and fluoroquinolones (including ciprofloxacin), highlighting the AMR burden created by these gene cassettes.
• Genetic Diversity and Epidemiology: 17 genotypes were identified, with type E and type G as the most prevalent. The highest detection rates were among male, elderly, and respiratory medicine patients, and sputum samples, indicating priority risk groups and clinical settings for targeted surveillance.
• Mobile Elements and Co-carrying Events: Most isolates harbored multiple mobile genetic elements, with ISEcp1 present in 87.04% (47/54), facilitating further dissemination within and between species.

Together, these findings reinforce the critical role of plasmid-mediated blaNDM-1 in driving multidrug resistance in CREC, and demonstrate how clinical and molecular surveillance in high-incidence departments can inform AMR containment strategies.

Comparison with Existing Internal Articles

Several recent internal reviews, such as “Ciprofloxacin: Mechanism, Benchmarks, and Research Integration” and “Ciprofloxacin as a Precision Probe: Dissecting Resistance Transmission”, emphasize the pivotal role fluoroquinolone antibiotics play in laboratory models of antimicrobial resistance. Both articles detail how ciprofloxacin’s mechanism—as a bacterial DNA gyrase and topoisomerase IV inhibitor—makes it a gold standard for studying DNA replication inhibition and resistance gene transfer. The current reference study builds on these principles by providing direct evidence that CEG-positive CREC isolates exhibit higher resistance to ciprofloxacin, aligning with prior observations that multidrug resistance often encompasses fluoroquinolone classes. These resources collectively support the design of bacterial infection models for resistance transmission and efficacy testing, and the reference study further contextualizes these models in a contemporary clinical outbreak setting.

Limitations and Transferability

While the study offers a rigorously detailed snapshot of CEG dynamics in southern China during the COVID-19 pandemic, certain limitations should be considered:

• Geographic Focus: Analysis is restricted to eight hospitals within one province, limiting generalizability to other regions or healthcare settings.
• Temporal Scope: The surveillance window (2022–2024) coincides with post-pandemic disruptions, which may have temporarily altered resistance patterns and gene transmission rates.
• Gene Panel: While comprehensive for blaNDM-1, blaIMP, and blaKPC-2, the study does not assess other emerging carbapenemase genes or resistance mechanisms.
• Clinical Outcome Data: Detailed patient outcome correlations were not explored, so the direct impact of specific genotypes on morbidity, mortality, or therapy failure remains to be investigated.

Nevertheless, the methodology and findings are highly transferable to laboratory workflows aiming to model or track antimicrobial resistance gene dissemination, especially in the context of fluoroquinolone mechanism of action and cross-resistance studies.

Protocol Parameters

• Sample stratification: Consider collecting isolates from diverse clinical departments and age groups to mirror real-world epidemiology as in the reference study.
• Plasmid elimination: Use variable temperature SDS protocol for distinguishing chromosomal versus plasmid gene localization.
• Antimicrobial panel selection: Include fluoroquinolones (e.g., ciprofloxacin at 1–4 µg/mL for broth microdilution assays) alongside carbapenems and aminoglycosides to capture multidrug resistance profiles.
• Conjugation efficiency assessment: Perform filter mating or broth conjugation with recipient strains, confirming transfer of CEGs by PCR and phenotypic resistance.
• Genotyping: Apply ERIC-PCR or similar fingerprinting for clonal relationship analysis and outbreak tracking.
• Mobile element identification: Use established PCR primers for frequent elements such as ISEcp1 to assess mobility potential.

Research Support Resources

To replicate or extend the findings of this study, researchers require validated antibiotics to serve as phenotypic markers of resistance and as tools for selective pressure in experimental models. Ciprofloxacin (SKU A8399), a research-grade fluoroquinolone antibiotic, offers well-characterized DNA gyrase and topoisomerase IV inhibition and is supplied at >98% purity for consistent laboratory use. Its defined mechanism and stability profile make it suitable for resistance profiling, gene transfer studies, and benchmarking multidrug-resistant isolates in antimicrobial resistance research. For further mechanistic details and protocol recommendations, consult the referenced internal reviews and the product dossier.